1 / 21

Regulatory Affairs

Regulatory Affairs. Pat Ward November 1, 2011. Purpose. Regulatory Good-Standing…. Purpose. Protect…. Employees Students Patients Research subjects Neighbors Research Education Training Environment Fiscal steward- ship Integrity Reputation.

nevina
Télécharger la présentation

Regulatory Affairs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Regulatory Affairs Pat Ward November 1, 2011

  2. Purpose • Regulatory Good-Standing…

  3. Purpose • Protect… Employees Students Patients Research subjects Neighbors Research Education Training Environment Fiscal steward- ship Integrity Reputation

  4. Products and Services • In general… • Maintain awareness • Regulations and other standards • Stakeholder interests (faculty, staff, students) • Connect the dots between requirements and stakeholder interests • Fact-finding, advice, problem resolution • Remediation of misconduct, misbehavior, non-compliance • Faculty disputes over research resources • Chaperone interactions with regulatory authorities

  5. Products and Services • OID and COI, in particular… • Operate Outside Interest Disclosure (OID) system (M-Inform) • Monitor external listings and resolve discrepancies • Review IRB and grant applications for Conflicts of Interest (COIs) • Negotiate, document, and monitor COI management plans (CMPs) • Support COI committees • MEDCOI, CECOIC, ICOI, OCs

  6. Products and Services Answer questions! (or help find answers to them)

  7. Customers • Internal • UMMS faculty, staff, students • Administrations at the UMMS division/department, center/institute, and school levels • UMHS Compliance, OVPR, and other central UM units • External • Oversight agencies • Government, accreditation, review boards

  8. Customers Partners (making new ones every day!) • BTS/BEU • CC-CTO • CECOIC • Compliance Office • Compliance Committee • DRDA • eRRM • eRPM • Facilities • Finance • FGP • FOIA • GTMLP • HAL • HIM • HR • IBC • ICOI • IDS • IRB Council • IRBMED • MCRU • MEDCOI • MICHR • MSIS • OAA • OCA • OFA • OGC • OHRCR • OoR • OSEH • OTT • OVPR • PR&M • QA • Risk Management • RPC/RDRC/SHUR • TPS • U-Audits • UCUCA • ULAM

  9. Staffing Trends • 2008 – present 2 FTE from OoR (General) + 3 FTE from Dean’s Office (OID/COI) 5 FTE in new RA office - 1 FTE attrition 4 FTE (late 2008 - early 2011) + 3 FTE (increase in requests for general assistance, 7 FTE expansion of COI to clinical and educational areas, political/media attention to OIDs)

  10. Current Tactical Initiatives New COI Rules • Develop and implement plan by August 2012… • Review OIDs of every investigator on every PHS grant at submission • Not just PI, not just when COI “checked”, not just if awarded • Investigator OID must be current (within 30 days) • Not just annual • COIs must be managed and details reported to NIH (60 days) • Not just yes-or-no • Additional training, reporting, public release/posting of COIs, elaborate investigation and documentation of minor non-compliance

  11. Current Tactical Initiatives Proposed IRB rules • Analyze and comment by October 26, 2011 • Possible benefits • Better calibrate level of review to level of risk • Eliminate most annual reviews • Harmonize disparities in various similar regulations • Possible pitfalls • Expand regulations to de-identified data/specimens • Expand regulations to non-federally funded research • Require elaborate IT security and consent even for low risk studies

  12. Current Tactical Initiatives Clinical and Educational COI • Recent policies • Industry funding of CME • Ghostwriting • Disclosure to students • Upcoming discussions • Promotional speaking • Consulting • Website for public disclosure of OIDs

  13. Current Tactical Initiatives FDA Regulatory Survival • Noncompliance • What went wrong and how to fix it • Inspections • Preparing for and responding to • Monitoring CAPA plan compliance • Faculty holding IND/IDEs • Know what they’re getting into

  14. Current Tactical Initiatives Misconduct or misbehavior • Investigations • Shorten TAT • Streamline steps and participants • Build investigative and assessment skills • Evidence chain-of-custody • Integrity of documentation

  15. Current Tactical Initiatives Dry Ice Shipping

  16. Opportunities for Collaboration & Synergy • RA improvement initiatives • Information management and tracking systems • Website renovation and high-priority messages • Outreach to internal stakeholders • Regulatory analysis • Synergies with UMMS units • Departmental liaisons • Work together to cover all angles (HR/FA, MICHR) • Sharing lessons learned (even painful ones!)

  17. Thank You

  18. Appendix

  19. Organizational Structure

  20. Key Performance Indicators • OID/COI • % OID compliance • # CMPs produced/monitored • eResearch review TAT • General • # Regulatory interactions facilitated • # Noncompliance cases facilitated • # Repeat violations avoided

  21. Benchmarked Data and Performance Comparing notes with peers at other institutions • University of Miami – FDA inspections • University of Minnesota – IND/IDE programs • MD Anderson – IND/IDE programs • Vanderbilt – Clinical data de-identification • Case Western – Clinical COI • Duke – International human research • Johns Hopkins – Human subject protection • Ohio State University – Animal management programs, new COI rule implementation • University of Pittsburgh – IND/IDE programs, COI systems, honest broker system • University of Wisconsin – Clinical trial registration • CTSA RKSP Leaders – IRB systems • University of California – Various regulatory concerns • University of Iowa – OID disclosure websites

More Related